Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2005 (Vol. 25, No. 6)


  • Many useful features for free
  • Geeks use it best
The open-source revolution is spreading in all directions. I’ve got to admit, I think any idea that makes Microsoft worry can’t be all bad. Molecular biologists will rejoice in the discovery of JEMBOSS, a graphical user interface for the European Molecular Biology Open Software Suite. Written as server-client applications, the client side is written in Java, enabling its use in Mac, Windows, and UNIX environments. JEMBOSS was derived from EMBOSS, which lacked the ease of use of the current version. The suite consists of about 100 programs that perform sequence alignments, rapid database searching, protein motif identification, pattern recognition, codon usage, and presentation tools. Like other open-source efforts, the price (free) is right, but you’ll have to be a bit of a techie to have the best success.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »